Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AGPU

Axe Compute Inc

Apr 22 • 12:56PM ET

8.86

+3.98 81.56 %

Technology • Software - Infrastructure • USA • NASD

Today, 8:06 AMAxe Compute (AGPU) inks largest‑ever 36‑month contract worth approximately $260M for a 2,304‑GPU NVIDIA B300 cluster in a U.S. Tier 3 data center

Peers: ILMN VCYT FLGT GH EXAS CDNA MYGN TWST QGEN CRSP

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-153.11	Insider Own	98.44%	Shs Outstand	4.08M	Perf Week	152.42%
Market Cap	49.07M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	-	Perf Month	443.56%
Enterprise Value	39.95M	PEG	-	EPS next Q	-	Inst Own	2.73%	Short Float	-	Perf Quarter	41.76%
Income	-233.28M	P/S	377.50	EPS this Y	-	Inst Trans	26.47%	Short Ratio	0.09	Perf Half Y	-4.83%
Sales	0.13M	P/B	0.76	EPS next Y	-	ROA	-804.87%	Short Interest	0.17M	Perf YTD	23.92%
Book/sh	11.69	P/C	4.55	EPS next 5Y	-	ROE	-980.14%	52W High	32.10 -72.40%	Perf Year	-33.80%
Cash/sh	1.95	P/FCF	-	EPS past 3/5Y	49.83% 54.21%	ROIC	-479.78%	52W Low	1.03 760.19%	Perf 3Y	-84.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-56.34% -36.90%	Gross Margin	-474.81%	Volatility	17.30% 30.06%	Perf 5Y	-97.27%
Dividend TTM	-	EV/Sales	307.35	EPS Y/Y TTM	-303.51%	Oper. Margin	-22688.58%	ATR (14)	1.11	Perf 10Y	-99.95%
Dividend Ex-Date	-	Quick Ratio	10.02	Sales Y/Y TTM	-92.43%	Profit Margin	-186197.06%	RSI (14)	83.36	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.02	EPS Q/Q	-657.32%	SMA20	140.86%	Beta	2.68	Target Price	45.00
Payout	-	Debt/Eq	0.03	Sales Q/Q	-98.58%	SMA50	234.39%	Rel Volume	70.01	Prev Close	4.88
Employees	14	LT Debt/Eq	0.02	Earnings	Mar 31 AMC	SMA200	12.67%	Avg Volume	1.89M	Price	8.86
IPO	Apr 09, 2010	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	73,140,612	Change	81.56%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-19-24	Initiated	H.C. Wainwright	Buy	$3

Today 10:30AM	BC-Most Active Stocks (Associated Press) +81.56%
08:00AM	Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment (GlobeNewswire)
Apr-20-26 08:00AM	Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve (GlobeNewswire) +31.25%
Apr-06-26 08:00AM	Axe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive Team (GlobeNewswire)
Apr-01-26 03:01PM	Axe Compute Inc (AGPU) Q4 2025 Earnings Call Highlights: Strategic Expansion and Strong ... (GuruFocus.com) +119.75%
10:30AM	Loading…
10:30AM	BC-Most Active Stocks (Associated Press)
08:00AM	Axe Compute Reports $12 Million in Executed Agreements Providing $835 Thousand in Estimated Monthly Income Entering Q2 2026 (GlobeNewswire)
Mar-31-26 04:30PM	Axe Compute Inc. Reports Full-Year 2025 Financial Results (GlobeNewswire) +10.20%
Mar-27-26 08:45AM	Axe Compute to Host Annual Report Conference Call (GlobeNewswire)
Mar-17-26 08:45AM	Axe Compute Appoints Two Technology and Telecom Luminaries to Board of Directors as Company Accelerates AI Infrastructure Strategy (GlobeNewswire)
Feb-24-26 08:00AM	Axe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus (GlobeNewswire)
Feb-09-26 08:00AM	Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute (GlobeNewswire) +6.09%
Jan-12-26 09:00AM	Axe Compute (NASDAQ: AGPU) Named Sponsor of the Sequire Investor Summit Puerto Rico 2026 (GlobeNewswire)
Dec-12-25 08:00AM	Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure (GlobeNewswire)
Dec-02-25 08:00AM	Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement (GlobeNewswire)
05:12PM	Loading…
Nov-14-25 05:12PM	Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy (GlobeNewswire) -6.17%
Oct-21-25 04:32AM	Aethir's $344M GPU DAT Looks To Move Crypto Treasuries From Michael Saylor's Strategy Model to Something More Sustainable (CCN)
Oct-14-25 08:00AM	Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy (GlobeNewswire)
Oct-08-25 09:00AM	Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy (GlobeNewswire)
Sep-30-25 07:32AM	New Binance Coin and Aethir Treasuries Raise Over $400M To Launch (CCN) -21.00%
Sep-29-25 05:33PM	Penny stock jumps 200% on thrilling crypto treasury announcement (TheStreet) +54.82%
09:07AM	Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens (GlobeNewswire)
Sep-25-25 08:00AM	Predictive Oncology Announces 1-for-15 Reverse Stock Split (GlobeNewswire) -19.47%
Sep-04-25 09:00AM	Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients (GlobeNewswire)
Aug-14-25 07:00AM	Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-15-25 09:00AM	Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities (GlobeNewswire)
Jul-08-25 09:00AM	Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing (GlobeNewswire) -5.88%
Jun-12-25 08:30AM	Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp (GlobeNewswire)
May-27-25 08:35AM	Court Denies Renovaro Motion for an Expedited Trial in July (GlobeNewswire) -7.28%
May-22-25 03:12PM	UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology (GlobeNewswire) -10.09%
11:05AM	Loading…
11:05AM	Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology (GlobeNewswire)
08:15AM	AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition (GlobeNewswire)
May-20-25 08:30AM	Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" (GlobeNewswire) +10.00%
May-15-25 07:00AM	Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
May-08-25 07:05PM	Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +5.94%
Apr-29-25 08:45AM	Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth (GlobeNewswire)
Apr-15-25 08:00AM	Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs (GlobeNewswire)
Apr-05-25 12:10PM	China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz (TipRanks)
Apr-04-25 09:40AM	Renovaro Provides Update to Definitive Agreement with Predictive Oncology (GlobeNewswire)
Apr-01-25 07:00AM	Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-27-25 05:33PM	Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research (InsiderMonkey) -5.23%
Mar-25-25 07:00AM	Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary (GlobeNewswire) +51.57%
Mar-20-25 07:00AM	Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries (GlobeNewswire)
Mar-03-25 09:15AM	Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology (GlobeNewswire) -9.35%
09:00AM	Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences (GlobeNewswire)
Feb-19-25 05:20PM	Predictive Oncology Closes Registered Direct Offering (GlobeNewswire) -23.08%
10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire)
08:00AM	Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Feb-18-25 03:41PM	Predictive Oncology (POAI) Struggles AI-Driven Drug Repurposing Breakthrough (Insider Monkey) +20.37%
08:00AM	Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing (GlobeNewswire)
Feb-10-25 08:00AM	Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis (GlobeNewswire)
Jan-16-25 08:00AM	Predictive Oncology Announces Planned European Launch of its ChemoFx Treatment Selection Marker and Tumor Profiling Assay (GlobeNewswire) +12.61%
Jan-07-25 09:15AM	Renovaro Issues Shareholder Letter and Provides Corporate Update (GlobeNewswire) -10.58%
Jan-06-25 09:15AM	Renovaro to Acquire Predictive Oncology in All-Stock Transaction (GlobeNewswire) +57.50%
09:10AM	Predictive Oncology Announces Agreement to be Acquired by Renovaro (GlobeNewswire)
Dec-03-24 07:00AM	Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives (GlobeNewswire)
Nov-13-24 07:00AM	Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update (GlobeNewswire)
Oct-09-24 06:23PM	Predictive Oncology Inc (POAI) Q2 2024 Earnings Call Highlights: Strategic Advances Amidst ... (GuruFocus.com)
Sep-05-24 08:00AM	Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-27-24 08:00AM	Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery (GlobeNewswire)
Aug-14-24 07:00AM	Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -12.38%
Aug-13-24 10:52PM	POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024 (InvestorPlace)
07:00AM	Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development (GlobeNewswire)
Aug-07-24 07:00AM	Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 (GlobeNewswire) -7.05%
Jul-26-24 08:00AM	Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds (GlobeNewswire) -26.20%
Jul-25-24 07:00AM	Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results (GlobeNewswire) +74.77%
Jun-28-24 06:00AM	7 F-Rated Growth Stocks to Avoid Right Now: June 2024 (InvestorPlace)
Jun-11-24 08:00AM	Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs) (GlobeNewswire) +8.94%
Jun-04-24 08:42AM	Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery (GlobeNewswire)
May-29-24 07:00AM	Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 2024 (GlobeNewswire) -7.43%
May-28-24 07:00AM	Predictive Oncology Announces Positive Results from Ovarian Cancer Study with UPMC Magee-Womens Hospital to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) +32.84%
May-15-24 09:52AM	POAI Stock Earnings: Predictive Oncology Reported Results for Q1 2024 (InvestorPlace)
07:00AM	Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-10-24 07:00AM	Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024 (GlobeNewswire) -7.39%
May-08-24 06:45AM	AI-Fueled Penny Stocks: 3 High-Risk, High-Reward Opportunities (InvestorPlace) +6.75%
May-06-24 07:28AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
May-01-24 07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +17.02%
Apr-30-24 04:05PM	Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine (GlobeNewswire) +5.22%
Apr-25-24 09:17AM	Fujifilm and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals (GlobeNewswire) +23.88%
Apr-24-24 04:05PM	Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-02-24 10:31AM	Predictive Oncology Inc. (NASDAQ:POAI) Q4 2023 Earnings Call Transcript (Insider Monkey) -9.69%
Mar-28-24 11:52PM	POAI Stock Earnings: Predictive Oncology Reported Results for Q4 2023 (InvestorPlace) -8.27% -10.98%
05:28PM	Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-21-24 04:05PM	Predictive Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.00%
Jan-02-24 07:00AM	Predictive Oncology to Participate in Upcoming San Francisco Conferences (GlobeNewswire) +7.14%
Nov-15-23 02:17PM	Predictive Oncology Inc. (NASDAQ:POAI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 07:00AM	Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-08-23 08:12AM	Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital (GlobeNewswire)
Nov-07-23 07:00AM	Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 (GlobeNewswire)
Aug-10-23 05:15PM	Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-03-23 08:00AM	Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023 (GlobeNewswire)
Jul-18-23 08:00AM	Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh (GlobeNewswire)
Jun-27-23 08:00AM	Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board (GlobeNewswire)
Jun-20-23 08:00AM	Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board (GlobeNewswire) +22.93%
May-23-23 08:30AM	Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention (GlobeNewswire)
May-15-23 05:15PM	Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -9.76% -19.88%
May-08-23 08:00AM	Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023 (GlobeNewswire) +10.12%
May-02-23 05:10PM	Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors (GlobeNewswire) +11.57% +5.35%
Apr-20-23 05:10PM	Predictive Oncology Announces Reverse Stock Split (GlobeNewswire) -32.43%
Apr-17-23 06:00PM	Predictive Oncology Adjourns Special Meeting of Stockholders (GlobeNewswire) -16.26% -9.77%

Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AGPU

Axe Compute Inc

Upgrade your Finviz experience